190 related articles for article (PubMed ID: 23320865)
1. Inflammation and cancer revisited: an hypothesis on the oncogenic potential of the apoptotic tumor cell.
Gregory CD
Autoimmunity; 2013 Aug; 46(5):312-6. PubMed ID: 23320865
[TBL] [Abstract][Full Text] [Related]
2. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
Mierke CT
Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
[TBL] [Abstract][Full Text] [Related]
3. Exploitation of Apoptotic Regulation in Cancer.
Ucker DS; Levine JS
Front Immunol; 2018; 9():241. PubMed ID: 29535707
[TBL] [Abstract][Full Text] [Related]
4. Antibodies as oncogenes: a hypothesis.
Admon A; Shoshan SH
Med Hypotheses; 2006; 67(3):471-3. PubMed ID: 16632230
[TBL] [Abstract][Full Text] [Related]
5. Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis.
Fond AM; Ravichandran KS
Adv Exp Med Biol; 2016; 930():25-49. PubMed ID: 27558816
[TBL] [Abstract][Full Text] [Related]
6. The inflammatory tumor microenvironment and its impact on cancer development.
de Visser KE; Coussens LM
Contrib Microbiol; 2006; 13():118-137. PubMed ID: 16627962
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity vs. cancer: predator vs. alien?
Berens C; Lauber K; Herrmann M
Autoimmunity; 2013 Aug; 46(5):287-93. PubMed ID: 23706137
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and cancer.
Singh N; Baby D; Rajguru JP; Patil PB; Thakkannavar SS; Pujari VB
Ann Afr Med; 2019; 18(3):121-126. PubMed ID: 31417011
[TBL] [Abstract][Full Text] [Related]
9. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.
Servais C; Erez N
J Pathol; 2013 Jan; 229(2):198-207. PubMed ID: 22996812
[TBL] [Abstract][Full Text] [Related]
10. Editorial overview: Autoimmunity: A new frontier awaits.
Stetson DB
Curr Opin Immunol; 2018 Dec; 55():iii-iv. PubMed ID: 30522628
[No Abstract] [Full Text] [Related]
11. Inflammation and cancer.
Coussens LM; Werb Z
Nature; 2002 Dec 19-26; 420(6917):860-7. PubMed ID: 12490959
[TBL] [Abstract][Full Text] [Related]
12. Killing Is Not Enough: How Apoptosis Hijacks Tumor-Associated Macrophages to Promote Cancer Progression.
Weigert A; Mora J; Sekar D; Syed S; Brüne B
Adv Exp Med Biol; 2016; 930():205-39. PubMed ID: 27558823
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors, tissue injury, and tumourigenesis.
Ioannou S; Voulgarelis M
Mediators Inflamm; 2010; 2010():. PubMed ID: 20871832
[TBL] [Abstract][Full Text] [Related]
14. Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.
Zadka Ł; Grybowski DJ; Dzięgiel P
Cell Oncol (Dordr); 2020 Aug; 43(4):539-575. PubMed ID: 32488850
[TBL] [Abstract][Full Text] [Related]
15. ADDR Editor's Collection 2017.
Ghandehari H
Adv Drug Deliv Rev; 2017 Dec; 122():1. PubMed ID: 29197465
[No Abstract] [Full Text] [Related]
16. The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology.
Sha W; Brüne B; Weigert A
Immunobiology; 2012 Dec; 217(12):1225-32. PubMed ID: 22727331
[TBL] [Abstract][Full Text] [Related]
17. Personalizing medicine for autoimmune and inflammatory diseases.
Chan AC; Behrens TW
Nat Immunol; 2013 Feb; 14(2):106-9. PubMed ID: 23334822
[TBL] [Abstract][Full Text] [Related]
18. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment.
Baglole CJ; Ray DM; Bernstein SH; Feldon SE; Smith TJ; Sime PJ; Phipps RP
Immunol Invest; 2006; 35(3-4):297-325. PubMed ID: 16916756
[TBL] [Abstract][Full Text] [Related]
19. Balancing the innate immune system in tumor development.
Hagerling C; Casbon AJ; Werb Z
Trends Cell Biol; 2015 Apr; 25(4):214-20. PubMed ID: 25444276
[TBL] [Abstract][Full Text] [Related]
20. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge LW; Estania AP; Guo Y; Liu W; Yang L
Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
